SCHEMBL29423939

SCHEMBL29423939

CCOC(=O)CCCOc1ccc(Br)c(C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 3/20 0.44
CYSLTR1 Q9Y271 3/20 0.44
PDE3B Q13370 2/20 0.41
PDE3A Q14432 2/20 0.41
P2RY12 Q9H244 1/20 0.41
BRD4 O60885 1/20 0.41
TNF P01375 2/20 0.40
TOP2A P11388 1/20 0.40
PTPN1 P18031 2/20 0.39
DHFR P00374 1/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
FAAH O00519 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16631687 0.79 NPC1 (0.39) CYP1A2CYP3A4CYP2C19L3MBTL1CYP2D6
SCHEMBL13213589 0.77 HTR7 (0.35) CYP1A2CYP2C19CYP2D6SMN1; SMN2
SCHEMBL6631228 0.77 CYSLTR2 (0.67) CYSLTR2CYSLTR1PDE3BPDE3AP2RY12
SCHEMBL15485538 0.76 NCF1 (0.39) PDE3BPDE3AP2RY12CYP1A2CYP3A4
SCHEMBL16334701 0.76 PDE4A (0.42) CYSLTR2CYSLTR1BRD4TNFPTPN1
SCHEMBL29129061 0.75 CYP4F2 (0.46) CYSLTR2CYSLTR1TOP2APTPN1L3MBTL1
SCHEMBL9469608 0.75 NPC1 (0.49) CYSLTR2CYSLTR1BRD4PTPN1DHFR
SCHEMBL29613406 0.75 CYP4F2 (0.46) CYSLTR2CYSLTR1TOP2APTPN1L3MBTL1
SCHEMBL24478464 0.75 BRD4 (0.55) CYSLTR2CYSLTR1PDE3BPDE3AP2RY12
SCHEMBL14570536 0.75 S1PR4 (0.49) CYSLTR2CYSLTR1PDE3BPDE3AP2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3974413-A1 ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2022-03-30 EP disclosed